Flash FinanceUS
Market closed S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · CDT Equity Inc. (CDT)

CDT Equity signs evaluation deal with Manoira, issues shares to settle $195,000 payment

Neutral Impact 3 of 5 product/contract Written later

CDT Equity entered an evaluation agreement dated October 22, 2026, under which Manoira Corporation will assess CDT's clinical-stage compounds AZD1656 and AZD5904 for its animal healthcare products. CDT issued 1,347,616 common shares at $0.1447 per share to settle a $195,000 payment due to Manoira, and the filing also reports other share issuances in the same period. Because the deal is an evaluation with no stated licensing terms yet, its value to shareholders is not yet clear, while the share issuances add to the number of shares outstanding.

Key points

  • Evaluation agreement with Manoira dated October 22, 2026; Manoira is preparing a first range of animal health products for launch in the first quarter of 2027.
  • 1,347,616 shares issued at $0.1447 per share to settle a $195,000 payment to Manoira.
  • Other unregistered issuances: 397,374 shares to a service provider, 437,779 shares to Sarborg Limited, and 499,616 shares to former CEO Dr. Andrew Regan in lieu of $65,000 severance.
  • Dr. Regan, a more-than-5% holder and sole director of Manoira, will receive no consideration from the Manoira deal; the filing lists one date as October 23, 3026, which appears to be a typo.

The filing

CompanyCDT Equity Inc. (CDT)
Form8-K, current report
Filed with the SECOct 27, 2026, 8:15 AM ET
Accession number0001493152-26-048638

Items reported: 1.01 Material Definitive Agreement3.02 Unregistered Equity Sale7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 11:44 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 27, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.